Robot model
Oryom
The JASPER Platform (formerly ORYOM) is the world's first robotic surgery platform for cataract and widespread ocular diseases.
- Manufacturer
- ForSight Robotics
- Form factor
- surgical
- Maturity
- pilot
- Lifecycle
- active
- Deployments
- 2
- Website
- forsightrobotics.com ↗
The verified answer
As of Sep 2026, DEPLOY verifies Oryom, a surgical by ForSight Robotics (pilot): 2 verified deployments on record. 1 source back the record.
Overview
The JASPER Platform (formerly ORYOM) is the world's first robotic surgery platform for cataract and widespread ocular diseases. It combines a 14-degree-of-freedom microsurgical robotic hand, 3D image guidance with segmentation, and AI-based data analytics to replicate and enhance conventional cataract surgery workflow. In April 2026, it performed the first fully robot-assisted cataract surgery in a human patient without general anesthesia.
Verified vs. claimed
- Maturity stage
- pilot(Small-scale deployment in controlled or trial conditions.)
- Sources on file
- View all sources →
Key facts
Form Factor
Maturity
Data & sources
Web sources
1
1 source backing this record.View all →
Autonomy: verified vs claimed
- What it actually does
- Teleoperated (human-controlled)
Pricing
No verified price is on record for Oryom. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (2)
ForSight Robotics performs world's first-in-human fully robot-assisted cataract surgery with JASPER platform.
First-in-human clinical trial (NCT07468409) at the Asian Eye Institute in Manila.
Oryom on the deployment map
View the global mapWhere Oryom is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 3, 2026
Added to the verified registry
- Deployment recordedApr 15, 2026
at Israel (IDF operations)
- Deployment verifiedVerifiedApr 1, 2026
at Manila, Philippines
Safety record
No incidents on record for Oryom.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
What is Oryom?
How much does Oryom cost?
Is Oryom actually deployed in the real world?
Who makes Oryom?
Where is Oryom deployed?
Can you buy Oryom?
What are alternatives to Oryom?
How does Oryom compare to da Vinci (and Ion)?
Is Oryom a top surgical?
What is Oryom's maturity stage?
Is Oryom safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-09
Maturity + lifecycle
Maturity stage: pilot
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Oryom.Machine-readable surfaces
- Markdown mirror: /models/oryom.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/e0a16a33-6e26-463a-acc0-b75455c21090
- Revision history: /models/oryom/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Oryom has insufficient attention data but verifies reality at the 64th percentile among surgical robots.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 17, 2026